Auxin response factors (ARFs) are important transcription factors that regulate the expression of early genes in response to auxin. Auxin is a crucial phytohormone that controls plant growth and development. Even though ARF genes have been identified in the cucumber (Cucumis sativus) genome version 3.0, the features of this gene family are unclear in the cucumber pan-genome and in the newly assembled genome v4.0. We identified a total of 18 CsARF genes, including two CsARF13s in Gy14. All ARF proteins, except ARF5 and 7, showed differences in protein length; all of them showed amino acid variation in the cucumber pan-genome, including 13 accessions. We also analyzed their organ-specific expression and their expression patterns in fruit development and in response to biotic stresses. Importantly, we found that the overexpression of CsARF12 significantly enhanced the resistance of cucumber cotyledons to gray mold infection. Therefore, this study lays a foundation for understanding the biological functions of CsARF genes and provides CsARF12 as a candidate gene to improve the cucumber resistance to gray mold.
Our aim of this work was the development of positively charged D-α-tocopheryl glycol succinate 1000 (TPGS)-chitosan nanocapsules (TCNs) as a non-viral vector for effective genome editing. A two-step process was used to create cationic TCNs. TPGS was initially esterified using succinic anhydride to add a carboxylic acid group. Then, using a complex coacervation technique, ionic cross-linking was used to join the activated TPGS with chitosan. Fourier transform infrared (FTIR) spectroscopy was used to validate the synthesis of TCNs. A gel retardation experiment was performed to evaluate TCNs/pDNA complex entrapments at various N/P ratios (2:1, 5:1, and 10:1). The physicochemical properties of the TCNs/pDNA complex were identified. Plasmid DNA was protected from DNase I activity through TCN complexation. HEK293 and GTM3 cell lines were used to test in vitro transfection efficiency. At N/P 5:1, TCNs/pDNA exhibited the maximum transfection efficiency, which was comparable to Lipofectamine 3000™. Cellular uptake and localization studies confirmed effective delivery of Cas9-GFP plasmids using TCNs. A T7 endonuclease mismatch detection assay further demonstrated effective targeting and editing of the MYOC gene in HEK293 cells using our TCN delivery system. Based on these findings, cationic TCNs represent a promising non-viral gene delivery platform for potential treatment of myocilin-associated glaucoma.
Cyanobacteria constitute a group of photooxybacteria. It is difficult to provide an estimate of their diversity due to the ongoing debate on the usefulness of various species concepts and methodologies used to delineate them. They occupy, thrive, and proliferate in diverse habitats, exhibiting unparalleled physiological plasticity and adaptations, potentiated by diverse mechanisms and the production of a range of novel molecules. Human use of cyanobacteria (and also other microalgae) and products thereof is not new, with reports from before 2700 BC. In recent times, some ecologically relevant molecules, such as cyanotoxins to deter grazers and osmoprotectants for survival in saline environments, have found multiple human uses, from feeding products to therapeutics and energy. Technological advancements have allowed precise identification and a better mechanistic understanding of their production on a commercial scale. Here, we discussed some of these commercially useful molecules and their production mechanisms, scaling-up possibilities, cost-effectiveness, and challenges and opportunities associated with future research.
Although cardiovascular diseases, especially diabetic cardiomyopathy (DCM), account for up to 80% of deaths in diabetic patients, the pathophysiological changes driven by diabetes on cardiovascular function are poorly defined and treated. As with many medical conditions, increased levels of Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Signal transducer and activator of transcription (STAT)3 are significant aspects of DCM pathophysiology. Research indicates that NF-κB dimer composition and nuclear (canonical) and mitochondrial (noncanonical) STAT3 interact across human cells to regulate the melatonergic pathway. Given the beneficial effects of melatonin across almost all cardiovascular diseases, including DCM, it is amiss that the melatonergic pathway has not been investigated in cardiomyocytes, cardiac fibroblast, or endothelial cells. In this article, we reviewed DCM pathophysiological factors/processes and link these to wider bodies of data on the regulation of the melatonergic pathway, providing a framework that better integrates previous disparate bodies of data on DCM, while indicating clear future research and treatment implications.
Cancer has emerged as a significant global health challenge, with both its occurrence and death toll rising annually. Studies have shown that early, precise diagnosis and targeted cancer therapy can effectively reduce the mortality rate of malignant tumors. As an emerging field, nanomedicine seeks to unify cancer diagnosis and therapy within a single platform, enabling early detection, precise drug targeting, and minimized harm to healthy tissues. In recent years, nanotechnology has emerged as a powerful tool in oncological applications, revolutionizing both cancer detection and therapeutic interventions, and clinical treatment strategies have also shown a significant trend of shifting from single therapy to combination therapy. Research demonstrates that multimodal combination therapy not only combines the benefits of individual treatment modalities but also generates synergistic effects, yielding significantly superior clinical outcomes compared to monotherapies or simple treatment combinations. Consequently, the integration of nanotechnology with multimodal synergistic approaches has emerged as an innovative paradigm in oncological therapeutics. This article provides a systematic review of the unique characteristics and functional mechanisms of various nanomaterials, while examining their translational applications in oncological diagnostics and therapeutics through nanomedicine approaches.
MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression and have been associated with pathological processes, including oncogenesis. In this study, the interaction between miRNAs and phosphoinositides, particularly phosphatidylinositol 4,5-bisphosphate (PIP2), was explored by pull-down assays, followed by RNA sequencing (RNA-seq) analysis in HeLa cells. Four miRNAs with specific affinity toward PIP2 and PI4P were identified, including hsa-miR-3181-1, hsa-miR-4720, hsa-miR-142, and hsa-miR-940. Structural analysis suggested that the interaction with lipids is mediated by secondary conformations rather than by sequence homology. Furthermore, two of these miRNAs were present in human blood fractions, with particular emphasis on hsa-miR-142, whose plasma distribution suggests a potential role as a phosphoinositide-mediated long-range signaling molecule. These miRNAs have been associated with tumor-related processes, suggesting a potential, although not yet confirmed, relevance as noninvasive biomarkers or therapeutic targets in cancer.